Same Indication

Nivolumab vs Sertraline

Nivolumab vs Sertraline: Overview

This comparison examines the pharmacological differences between Nivolumab and Sertraline.

Mechanism of Action

Nivolumab: Fully human anti-PD-1 IgG4 monoclonal antibody restoring T-cell anti-tumor activity.

Sertraline: Selective serotonin reuptake inhibitor (SSRI).

Pharmacokinetics

Half-life: Nivolumab — 27 days; Sertraline — 26 hours.

Chemical Properties

Molecular Formula: Sertraline — C17H17Cl2N.

Molecular Weight: Sertraline — 306.2290 g/mol.

Type: Nivolumab — Antibody; Sertraline — Small molecule.